The four bivalent monoclonal IgG
antibodies and proteins used in the experiments were designed, expressed,
and purified according to earlier published work.6 (link),21 (link) The
RmAb158 monoclonal antibodies selectively bind to Aβ protofibrils,22 (link) whereas the RmAb2G7 monoclonal antibodies selectively
bind to high-mobility group box 1 (HGMB1) proteins.23 (link) In short, the heavy and light chain scFv8D3 transferrin
receptor transporter variable region sequence20 (link) was connected to the C-terminus of the RmAb2G7 or RmAb158 light
chain with in-house designed linkers (APGSYTGSAPG or APGSGTGSAPG,
respectively). Figure 2 shows the cartoon representations of the antibody design, showing
the location of conjugated scFv8D3 in the modified antibodies.
The four recombinant antibodies were expressed
using Expi293 cells
(Thermo Fisher) transiently transfected with pcDNA3.4 vectors using
polyethyleneimine (PEI) as the transfection reagent. All antibodies
were purified on a protein G column (Cytiva) and eluted with an increasing
gradient of 0.7% acetic acid. The buffer was exchanged for phosphate-buffered
saline (PBS) (Gibco) immediately after elution, and the protein concentration
was determined at A280.
Free full text: Click here